Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Proposal to Have Empagliflozin as Option for Children with Type 2 Diabetes

SHEM OIREREApril 19, 2023

Tag: Empagliflozin , type 2 diabetes , SGLT 2 Inhibitors

PharmaSources Customer Service